<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>OptimDosing Blog</title>
    <link>https://optimdosing.com/blog.html</link>
    <description>Practitioner-oriented deep dives from OptimDosing on multi-drug dose optimization and symptom-trigger analytics.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 07 Nov 2025 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://optimdosing.com/blog/rss.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>Why multi‑drug regimens are the silent epidemic: the scale of polypharmacy in the U.S.</title>
      <link>https://optimdosing.com/blog/polypharmacy-prevalence-why-it-matters.html</link>
      <guid>https://optimdosing.com/blog/polypharmacy-prevalence-why-it-matters.html</guid>
      <pubDate>Fri, 07 Nov 2025 00:00:00 +0000</pubDate>
      <description>How many adults take five or more medications, and what this means for dose‑optimization and symptom‑trigger analytics.</description>
    </item>
    <item>
      <title>Chronic Polypharmacy — One‑pager</title>
      <link>https://optimdosing.com/blog/chronic-polypharmacy-one-pager.html</link>
      <guid>https://optimdosing.com/blog/chronic-polypharmacy-one-pager.html</guid>
      <pubDate>Fri, 07 Nov 2025 00:00:00 +0000</pubDate>
      <description>Prevalence, unmet need, and how OptimDosing models regimen-level safety—ready to share with partners.</description>
    </item>
    <item>
      <title>Combination Oncology — One‑pager</title>
      <link>https://optimdosing.com/blog/combination-oncology-one-pager.html</link>
      <guid>https://optimdosing.com/blog/combination-oncology-one-pager.html</guid>
      <pubDate>Fri, 07 Nov 2025 00:00:00 +0000</pubDate>
      <description>BD‑ready summary of OptimDosing's value in multi‑agent oncology dosing.</description>
    </item>
  </channel>
</rss>

